Characterization of the immune response to canine factor IX following AAV-mediated intravascular gene delivery to skeletal muscle in hemophilia B dogs.

被引：0
|
作者：
Hui, DJ
Mingozzi, F
Sabatino, DE
Mccorquodale, S
Dillow, A
Nichols, TC
Arruda, VR
High, KA
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：377A / 377A
页数：1
相关论文
共 50 条
  • [41] Skeletal muscle-specific expression of human blood coagulation factor Ⅸ rescues factor Ⅸ deficiency mouse by AAV-mediated gene transfer
    赖立辉
    陈立
    卢大儒
    王琪
    高啸波
    邱信芳
    Jerry L.Hsueh
    薛京伦
    王健民
    周虹
    [J]. Science China Life Sciences, 1999, (06) : 628 - 634
  • [42] Automated whole blood tests for monitoring canine factor IX activity following gene therapy of hemophilia B
    Nichols, TC
    Merricks, EP
    Raymer, RA
    Read, MS
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 280 - 280
  • [43] Successful AAV vector-mediated gene transfer into canine skeletal muscle required suppression of excess immune responses
    Yuasa, K
    Yoshimura, M
    Urasawa, N
    Sato, K
    Miyagoe-Suzuki, Y
    Howell, JM
    Takeda, S
    [J]. MOLECULAR THERAPY, 2004, 9 : S94 - S94
  • [44] Complete Correction of Severe Canine Hemophilia B By Skeletal Muscle Directed AAV-Based FIX-Padua Gene Therapy in Inhibitor-Prone Dogs
    French, Robert
    Martin, Nicholas
    Nichols, Timothy C.
    Niemeyer, Glenn P.
    Lothrop, Clinton D.
    Arruda, Valder R.
    [J]. BLOOD, 2015, 126 (23)
  • [45] AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
    Gatto, Francesca
    Rossi, Barbara
    Tarallo, Antonietta
    Polishchuk, Elena
    Polishchuk, Roman
    Carrella, Alessandra
    Nusco, Edoardo
    Alvino, Filomena Grazia
    Iacobellis, Francesca
    De Leonibus, Elvira
    Auricchio, Alberto
    Diez-Roux, Graciana
    Ballabio, Andrea
    Parenti, Giancarlo
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [46] AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
    Francesca Gatto
    Barbara Rossi
    Antonietta Tarallo
    Elena Polishchuk
    Roman Polishchuk
    Alessandra Carrella
    Edoardo Nusco
    Filomena Grazia Alvino
    Francesca Iacobellis
    Elvira De Leonibus
    Alberto Auricchio
    Graciana Diez-Roux
    Andrea Ballabio
    Giancarlo Parenti
    [J]. Scientific Reports, 7
  • [47] TALEN Mediated Gene Correction of Coagulation Factor IX Via Homologous Recombination in Context of a Canine Hemophilia B Model
    Bergmann, Thorsten
    Schulz, Eric
    Gebbing, Maren
    Schildgen, Verena
    Schildgen, Oliver
    Ehrhardt, Anja
    [J]. MOLECULAR THERAPY, 2014, 22 : S219 - S219
  • [48] Six-year follow-up of inhibitor prone hemophilia B dogs treated with muscle and liver-directed AAV2 mediated factor IX gene therapy.
    Niemeyer, Glenn P.
    Herzog, Roland W.
    Mount, Jane D.
    Arruda, Valder
    Tillson, Michael
    Hathcock, John
    High, Katherine A.
    Lothrop, Clinton D.
    [J]. BLOOD, 2006, 108 (11) : 937A - 937A
  • [49] Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
    Arruda, VR
    Schuettrumpf, J
    Herzog, RW
    Nichols, TC
    Robinson, N
    Lotfi, Y
    Mingozzi, F
    Xiao, WD
    Couto, LB
    High, KA
    [J]. BLOOD, 2004, 103 (01) : 85 - 92
  • [50] Macaque immune responses following AAV-based gene transfer to the skeletal muscle: addressing the method of vector delivery
    Gernoux, Gwladys
    Devaux, Marie
    Dubreil, Laurence
    Jaulin, Nicolas
    Guilbaud, Mickael
    Deschamps, Jack-Yves
    Larcher, Thibaut
    Guigand, Lydie
    Dutilleul, Maeva
    Cherel, Yan
    Moullier, Philippe
    Adjali, Oumeya
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A130 - A130
12345